REGENXBIO Inc.
RGNX
$6.72
$0.172.60%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -12.33% | 8.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.33% | 8.53% | |||
| Cost of Revenue | -327.23% | 337.33% | |||
| Gross Profit | 506.01% | -707.37% | |||
| SG&A Expenses | -22.51% | 3.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 2,151.35% | 27.59% | |||
| Total Operating Expenses | -15.87% | 10.14% | |||
| Operating Income | 17.25% | -10.78% | |||
| Income Before Tax | 14.11% | -12.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.11% | -12.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.11% | -12.47% | |||
| EBIT | 17.25% | -10.78% | |||
| EBITDA | 18.54% | -11.79% | |||
| EPS Basic | 14.23% | -12.03% | |||
| Normalized Basic EPS | 14.23% | -12.02% | |||
| EPS Diluted | 14.23% | -11.73% | |||
| Normalized Diluted EPS | 14.23% | -12.02% | |||
| Average Basic Shares Outstanding | 0.14% | 0.39% | |||
| Average Diluted Shares Outstanding | 0.14% | 0.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
